Glucosamine: Market Research Report

August 2011 | 449 pages | ID: GBE45A3A996EN
Global Industry Analysts, Inc

Abstracts

This report analyzes the worldwide markets for Glucosamine in Metric Tons.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World.

Annual estimates and forecasts are provided for the period 2009 through 2017.

A six-year historic analysis is also provided for these markets.

The report profiles 148 companies including many key and niche players such as Alcan Chemical Division, Alfa Chem, Cargill, Inc., CMP Therapeutics Ltd., Dalian Lijian Bio-Technology Development Co., Ltd., Dalian Xindie Chitin Co., Ltd., Dee Pharmaceuticals Ltd., Ethical Naturals, Inc., FabriChem, Inc., Golden-Shell Biochemical Co., Ltd., Koyo Chemical Company Limited, Navamedic ASA, Nutraceutix, Inc., Nutramax Laboratories, Inc., NUTRILITE, Promax Nutrition Corporation, Schiff Nutrition International, Inc., Shandong DongYing Development Zone Marine Biochemical Co., Ltd., Shandong Jinan Haidebei Marine BioengineeringCo.Ltd., Simply Supplements, Synasia, Inc., Taizhou Candorly Sea Biochemical & Health Products Co., Ltd., Triarco Industries, Inc., Xiamen Blue Bay Science & Technology Co., Ltd., and Zhejiang Freeman Shinfuda Co.Ltd.

Market data and analytics are derived from primary and secondary research.

Company profiles are mostly extracted from URL research and reported select online sources.

Contents

1.INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study

2.MARKET OVERVIEW

Glucosamine: The Leading Dietary Supplement in the Joint Health Market
Global Market Analysis
Market Trends
Nutritional Supplements Industry Remains Resilient to Economic Downturn
Aging Population Drives Glucosamine Market

Table 1. Worldwide Distribution of 65+ Population by Region/Country: As on July 2009 (includes corresponding Graph/Chart)

China Races Ahead in Glucosamine Production and Supply Worldwide
Newer Formulations of Glucosamine Being Introduced
Glucosamine Fortification: An Emerging Trend

Table 2. Glucosamine Product Launches by Region (2006-2009): Asia-Pacific, North America, and Europe (includes corresponding Graph/Chart)

Plant-Derived Glucosamine Gains Popularity
Combination Supplements: A Double Whammy Success
Select Combination Supplements At a Glance
Functional Food and Beverages: Promising End-Market for Glucosamine
Alternative Joint Health Ingredients May Have an Impact on Future Sales

3.PRODUCT OVERVIEW

Glucosamine and the Benefits Offered
Why Glucosamine Supplements?
Chitin and Chitosan: A Prelude
Manufacturing of Glucosamine
Forms of Glucosamine
Glucosamine Sulfate Takes the Front Seat
Glucosamine Hydrochloride: Efficacy Still Doubted
Glucosamine and Recommended Dose
Glucosamine Interactions
Combo Power: Glucosamine Plus Other Ingredients
Diverse Views on Glucosamine/Chondroitin Use for Osteoarthritis Treatment
CosaminDS Ranked No.1
Shifting Preferences Towards Glucosamine Plus MSM Supplement
Glucosamine and Omega-3 Fatty Acids: A New Combination
Select Glucosamine Supplements Available in the Market – A Review
Oral Glucosamine
Osteo Bi-Flex® (NBTY, Inc.)
Move Free® Advanced (Schiff Nutrition Group, Inc.)
Cosamin® DS (Nutramax Laboratories, Inc)
TripleFlex® (Pharmavite LLC)
Vegetarian Glucosamine
Regenasure® (Cargill)
Regenasure Applications by Select Country
JointAstin (Cyanotech)
Liquid Vegetarian Glucosamine/MSM (Trace Minerals Research)
Avoca® ASU (Nutramax Laboratories, Inc.)
GlucosaGreen (Hygieia Health)
GreenGrown glucosamine (Ethical Naturals, Inc.)
Liquid Glucosamine
Major Liquid Glucosamine Brands
Topical Glucosamine Still Inferior Over Other Formulations
Urah™ TGC: A Topical Glucosamine Brand

4.NEW RESEARCH FINDINGS ON GLUCOSAMINE

High Doses of Glucosamine Supplements Can Increase Diabetes Risk
Zero Adverse Affects of Oral Glucosamine on Glucose Metabolism
Glucosamine Fails to Relieve Lower Back Pain
Positive Affects of Glucosamine Sulfate and Omega-3 Combo on Joint Health
Eggshell Membrane Outweighs Glucosamine for Joint Health Under ESM Funded Clinical Trial
Prolonged Use of High Purity and Concentrated Chondroitin Sulphate May Avoid Joint Degradation
InterHealth’s Patented Collagen Ingredient Outperforms Glucosamine and Chondroitin for Joint Health
Glucosamine to Treat UV- Related Skin Damage
Glucosamine Feared to Affect Fertility

5.PRODUCT INTRODUCTIONS AND LAUNCHES

Simply Supplements Launches Glucosamine Supplements for Bone Health
OXIS Launches ErgoFlex™ Dietary Supplements
MonaVie Introduces MonaVie Active and MonaVie Original
Forum Health to Launch Glucosamine Hydrochloride Supplement
Nutramax Launches Start Cosamin® ASU Program
Schiff Nutrition Rolls Out Move Free® Advanced, the Next-generation Joint Care Product
Nutrilite Unveils Glucosamine-7 for Better Joint Comfort in Shorter Period
Promax Nutrition Launches Joint Xpress™
Cargill and The Elations Company to Introduce the Elations® Joint Health Supplement Beverages
Triarco Launches Liquid Glucosamine
Ethical Naturals Rolls Out GreenGrown Glucosamine
Planet Nutrition Introduces Planet Nutrition Supplements Range
Pharma Base Introduces Osamine™ Pharmaceutical Grade Glucosamine
Dr Organics Unveils Body Shot
Navamedic Launches Mobilat Glucosamin
Health Perception Launches GlucOsamax Extra
Herbalife Unveils a Series of Anti-Aging Products Containing Glucosamine
Schiff Nutrition Launches New Move Free® Advanced
Reno Introduces New Liquid Dietary Supplement
Health Perception Launches ArheumaCare
Neptune Technologies Introduces Glucosamine/NKO™
BR Pharmaceuticals Reintroduces Valupak

6.RECENT INDUSTRY ACTIVITY

Corwin Beverage to Distribute TandemRain’s Sports Rejuvenation Products
Dee Pharma Signs Exclusive Permanent Distribution Deal with Laboratoires Expanscience
Thai Union and Nippon Suisan Joint Venture to Manufacture Glucosamine
Camlin Fine Chemicals to Foray into the US and European Markets
Ethical Naturals and Cargill Reconciles Glucosamine Patent Dispute
Koyo Chemical to Expand Product Portfolio
Bayer HealthCare Acquires OTC Business of Sagmel
Hygieia Receives EU Approval for GlucosaGreen, a Vegetarian Glucosamine
Navamedic Inks Agreement with Queisser Pharma
Lescarden Receives First Poly-NAG Order from Pascual Laboratories
Navamedic Divests ChitiNor to Seagarden
Navamedic Enters into a Deal with William Ransom
Navamedic Signs Agreement with French Partner to Market Glucomed

7.FOCUS ON SELECT PLAYERS

Alcan Chemical Division (US)
Alfa Chem (US)
Cargill, Inc. (US)
CMP Therapeutics Ltd. (UK)
Dalian Lijian Bio-Technology Development Co., Ltd (China)
Dalian Xindie Chitin Co., Ltd. (China)
Dee Pharmaceuticals Ltd (UK)
Ethical Naturals, Inc. (US)
FabriChem, Inc. (US)
Golden-Shell Biochemical Co., Ltd. (China)
Koyo Chemical Company Limited (Japan)
Navamedic ASA (Norway)
Nutraceutix, Inc. (US)
Nutramax Laboratories, Inc. (US)
NUTRILITE (US)
Promax Nutrition Corporation (US)
Schiff Nutrition International, Inc. (US)
Shandong DongYing Development Zone Marine Biochemical Co., Ltd. (China)
Shandong Jinan Haidebei Marine Bioengineering Co. Ltd. (China)
Simply Supplements (UK)
Synasia, Inc. (US)
Taizhou Candorly Sea Biochemical & Health Products Co., Ltd. (China)
Triarco Industries, Inc (USA)
Xiamen Blue Bay Science & Technology Co., Ltd (China)
Zhejiang Freeman Shinfuda Co. Ltd. (China)

8.GLOBAL MARKET PERSPECTIVE

Table 3. World Recent Past, Current & Future Analysis for Glucosamine by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in Metric Tons for Years 2009 through 2017 (includes corresponding Graph/Chart)

Table 4. World Historic Review for Glucosamine by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in Metric Tons for Years 2003 through 2008 (includes corresponding Graph/Chart)

Table 5. World 15-Year Perspective for Glucosamine by Geographic Region – Percentage Breakdown of Volume Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets for Years 2003, 2010 & 2017 (includes corresponding Graph/Chart)

9.THE UNITED STATES

A. MARKET ANALYSIS

Current and Future Analysis
Arthritis: A Major Cause of Disability Among Elderly
Glucosamine: A Good Fit for Joint Problems
Market Overview
Key Trends & Issues
Private Label Emerges as a Popular Choice Amid Recession
Glucosamine Containing Products Grow in Number
Product Introductions
Strategic Corporate Developments
Focus on Select Players

B. MARKET ANALYTICS

Table 6. The US Recent Past, Current & Future Analysis for Glucosamine - Annual Sales Figures in Metric Tons for Years 2009 through 2017 (includes corresponding Graph/Chart)

Table 7. The US Historic Review for Glucosamine - Annual Sales Figures in Metric Tons for Years 2003 through 2008 (includes corresponding Graph/Chart)

10.CANADA

Market Analysis

Table 8. Canadian Recent Past, Current & Future Analysis for Glucosamine - Annual Sales Figures in Metric Tons for Years 2009 through 2017 (includes corresponding Graph/Chart)

Table 9. Canadian Historic Review for Glucosamine - Annual Sales Figures in Metric Tons for Years 2003 through 2008 (includes corresponding Graph/Chart)

11.JAPAN

A. MARKET ANALYSIS

Strategic Corporate Development
Koyo Chemical Company Limited – A Key Player

B. MARKET ANALYTICS

Table 10. Japanese Recent Past, Current & Future Analysis for Glucosamine - Annual Sales Figures in Metric Tons for Years 2009 through 2017 (includes corresponding Graph/Chart)

Table 11. Japanese Historic Review for Glucosamine - Annual Sales Figures in Metric Tons for Years 2003 through 2008 (includes corresponding Graph/Chart)

12.EUROPE

A. MARKET ANALYSIS

The United Kingdom: A High Growth Market for Vitamins, Minerals and Supplements

Table 12. UK Market for Vitamins, Minerals, and Supplements (2007): Percentage Market Share Breakdown for Multivitamins, Fish Oils, Single Vitamins, Glucosamine, Evening Primrose & starflower Oils, Minerals, and Others (includes corresponding Graph/Chart)

Table 13. UK Life Expectancy by Gender (1950-2020) (includes corresponding Graph/Chart)

Product Introductions
Strategic Corporate Developments
Focus on Select Players

B. MARKET ANALYTICS

Table 14. European Recent Past, Current & Future Analysis for Glucosamine by Geographic Region – France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in Metric Tons for Years 2009 through 2017 (includes corresponding Graph/Chart)

Table 15. European Historic Review for Glucosamine by Geographic Region – France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in Metric Tons for Years 2003 through 2008 (includes corresponding Graph/Chart)

Table 16. European 15-Year Perspective for Glucosamine by Geographic Region – Percentage Share Breakdown of Volume Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2003, 2010 and 2017 (includes corresponding Graph/Chart)

12A.FRANCE

Market Analysis

Table 17. French Recent Past, Current & Future Analysis for Glucosamine - Annual Sales Figures in Metric Tons for Years 2009 through 2017 (includes corresponding Graph/Chart)

Table 18. French Historic Review for Glucosamine - Annual Sales Figures in Metric Tons for Years 2003 through 2008 (includes corresponding Graph/Chart)

12B.GERMANY

Market Analysis

Table 19. German Recent Past, Current & Future Analysis for Glucosamine - Annual Sales Figures in Metric Tons for Years 2009 through 2017 (includes corresponding Graph/Chart)

Table 20. German Historic Review for Glucosamine - Annual Sales Figures in Metric Tons for Years 2003 through 2008 (includes corresponding Graph/Chart)

12C.ITALY

Market Analysis

Table 21. Italian Recent Past, Current & Future Analysis for Glucosamine - Annual Sales Figures in Metric Tons for Years 2009 through 2017 (includes corresponding Graph/Chart)

Table 22. Italian Historic Review for Glucosamine - Annual Sales Figures in Metric Tons for Years 2003 through 2008 (includes corresponding Graph/Chart)

12D.THE UNITED KINGDOM

Market Analysis

Table 23. The UK Recent Past, Current & Future Analysis for Glucosamine - Annual Sales Figures in Metric Tons for Years 2009 through 2017 (includes corresponding Graph/Chart)

Table 24. The UK Historic Review for Glucosamine - Annual Sales Figures in Metric Tons for Years 2003 through 2008 (includes corresponding Graph/Chart)

12E.SPAIN

Market Analysis

Table 25. Spanish Recent Past, Current & Future Analysis for Glucosamine - Annual Sales Figures in Metric Tons for Years 2009 through 2017 (includes corresponding Graph/Chart)

Table 26. Spanish Historic Review for Glucosamine - Annual Sales Figures in Metric Tons for Years 2003 through 2008 (includes corresponding Graph/Chart)

12F.RUSSIA

Market Analysis

Table 27. Russian Recent Past, Current & Future Analysis for Glucosamine - Annual Sales Figures in Metric Tons for Years 2009 through 2017 (includes corresponding Graph/Chart)

Table 28. Russian Historic Review for Glucosamine - Annual Sales Figures in Metric Tons for Years 2003 through 2008 (includes corresponding Graph/Chart)

12G.REST OF EUROPE

Market Analysis

Table 29. Rest of Europe Recent Past, Current & Future Analysis for Glucosamine - Annual Sales Figures in Metric Tons for Years 2009 through 2017 (includes corresponding Graph/Chart)

Table 30. Rest of Europe Historic Review for Glucosamine - Annual Sales Figures in Metric Tons for Years 2003 through 2008 (includes corresponding Graph/Chart)

13.ASIA-PACIFIC

A. MARKET ANALYSIS

China - Poised to Become Major Glucosamine Consumer
Arthritis in Australia
Product Introductions
Focus on Select Players

B. MARKET ANALYTICS

Table 31. Asia-Pacific Recent Past, Current & Future Analysis for Glucosamine - Annual Sales Figures in Metric Tons for Years 2009 through 2017 (includes corresponding Graph/Chart)

Table 32. Asia-Pacific Historic Review for Glucosamine - Annual Sales Figures in Metric Tons for Years 2003 through 2008 (includes corresponding Graph/Chart)

14.REST OF WORLD

Market Analysis

Table 33. Rest of the World Recent Past, Current & Future Analysis for Glucosamine - Annual Sales Figures in Metric Tons for Years 2009 through 2017 (includes corresponding Graph/Chart)

Table 34. Rest of the World Historic Review for Glucosamine - Annual Sales Figures in Metric Tons for Years 2003 through 2008 (includes corresponding Graph/Chart)

COMPETITIVE LANDSCAPE

Total Companies Profiled: 148 (including Divisions/Subsidiaries - 150)
Region/CountryPlayers
The United States
Canada
Japan
Europe
Germany
The United Kingdom
Italy
Spain
Rest of Europe
Asia-Pacific (Excluding Japan)
Africa